Prenetics Global Limited (PRE) News
Follow Prenetics Global Limited (PRE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 15 public stories across 11 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
IM8 Named NBA Nutrition Partner in Australia and Southeast Asia
IM8 was named the NBA’s official nutrition partner in Australia and Southeast Asia.
EQUITY | Oct 12, 2026, 01:28 PM UTC
M
Bridgepoint Lifts FY Earnings Guidance, Shares Spark
Alternative asset manager Bridgepoint now expects performance-related earnings to be around 37% to 39% of total income for the year to December 2026, an increase from previous guidance of 20% to 25%.
EARNINGS | Oct 07, 2026, 09:01 AM UTC
L
Predict H1 Sales Revenue €4.01 Mln
Predict SpA MIL:PRE
NEWS | Sep 25, 2026, 04:44 PM UTC
L
Pensana Announces Construction Schedule For Longonjo Mine Extended To Late 2028
Pensana PLC LSE:PRE
NEWS | Sep 25, 2026, 06:20 AM UTC
H
Prenetics Global Q2 2026 Earnings Call: Complete Transcript
Prenetics Global (NASDAQ: PRE ) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For re
LIVE | Sep 21, 2026, 08:40 AM UTC
L
Prenetics Global price target set at $37.00 by B. Riley
B. Riley Securities announced a $37.00/share price target for Prenetics Global.
EQUITY | Aug 27, 2026, 05:54 PM UTC
L
PRE - Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
PRE - Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
EARNINGS | Aug 26, 2026, 12:47 PM UTC
L
Prenetics' IM8 names Lily Collins global ambassador, shareholder
Prenetics' IM8 announces actress and producer Lily Collins as its global ambassador and shareholder in a multi-year partnership.
MNA | Aug 20, 2026, 01:01 PM UTC
L
Prenetics Global initiates FY2027 guidance for $400M+ IM8 revenue
Prenetics Global (NASDAQ: PRE) initiates FY2027 guidance, targeting $400 million+ in IM8 revenue.
EARNINGS | Aug 18, 2026, 11:35 AM UTC
L
Prenetics’ IM8 reports Q2 2026 revenue +288% YoY; guides FY 2026 higher
Prenetics (PRE) says its IM8 reported Q2 2026 revenue growth of 288% YoY and raises FY 2026 IM8 revenue guidance to $220—230 million.
EARNINGS | Aug 18, 2026, 11:30 AM UTC
L
PRE appoints Caroline Levy, veteran consumer analyst, as independent director
Prenetics, the parent of IM8, appoints II-ranked Caroline Levy, a veteran Wall Street consumer analyst, as an independent director.
REGULATION | Aug 17, 2026, 12:32 PM UTC
L
PRE PT raised from $30 to $40, maintains Buy @ Benchmark
PRE PT raised from $30 to $40, maintains Buy @ Benchmark
EQUITY | Jul 15, 2026, 01:23 PM UTC
H
Sector Update: Healthcare Stocks Fall Late Afternoon
() -- Healthcare stocks fell late Tuesday afternoon with the NYSE Healthcare Index declining 1.7% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 1.9%. The iShares Biotechnology ETF (IBB) shed 0.4%
EARNINGS | Jul 14, 2026, 07:46 PM UTC
H
Prenetics Global Announces Closing Of $1B In Growth Financing From General Catalyst’s Customer Value Fund; Co. Raises FY26 IM8 Revenue Guida
IM8 is the fastest-growing premium supplement brand ever recorded — over 50 million servings delivered to date, with approximately 200,000 servings currently delivered daily, and an order every 27 seconds Prenetics raise
EARNINGS | Jul 14, 2026, 06:01 PM UTC
H
PRE Prenetics’ im8 secures $1B growth financing from general catalyst’s customer value fund (cvf) Prenetics global Ltd: raises full-year 202
PRE Prenetics’ im8 secures $1B growth financing from general catalyst’s customer value fund (cvf) Prenetics global Ltd: raises full-year 2026 im8 revenue guidance to $210–220M, up from $190–210M - Im8 expected to deliver
EARNINGS | Jul 14, 2026, 05:28 PM UTC